TipRanks
Advertisement
Advertisement
Teva Recasts Segments to Support Pivot to Growth
PremiumCompany AnnouncementsTeva Recasts Segments to Support Pivot to Growth
11d ago
Vaxcyte names Luis Jodar chief medical officer, David McAvoy chief legal officer
Premium
The Fly
Vaxcyte names Luis Jodar chief medical officer, David McAvoy chief legal officer
11d ago
J.P. Morgan’s Salveen Richter Reiterates Buy on Teva, Citing TEV-408 Phase 2a Success and Pipeline-in-a-Product Potential
Premium
Ratings
J.P. Morgan’s Salveen Richter Reiterates Buy on Teva, Citing TEV-408 Phase 2a Success and Pipeline-in-a-Product Potential
11d ago
Teva unit bids to acquire neuroscience product from BioXcel Therapeutics
PremiumThe FlyTeva unit bids to acquire neuroscience product from BioXcel Therapeutics
17d ago
BioXcel Therapeutics enters asset sale agreement with Teva
Premium
The Fly
BioXcel Therapeutics enters asset sale agreement with Teva
17d ago
Aurinia settles patent litigation with Teva
Premium
The Fly
Aurinia settles patent litigation with Teva
26d ago
AI Models Turn More Constructive on Teva Pharmaceutical (TEVA) as Earnings and Margins Improve
PremiumAI Analyst RatingsAI Models Turn More Constructive on Teva Pharmaceutical (TEVA) as Earnings and Margins Improve
2M ago
Teva Earnings Call Highlights Innovative Growth Shift
Premium
Company Announcements
Teva Earnings Call Highlights Innovative Growth Shift
2M ago
Morning Movers: Generac, Amphenol climb following earnings
Premium
The Fly
Morning Movers: Generac, Amphenol climb following earnings
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100